213 related articles for article (PubMed ID: 29463561)
1. Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset.
Hülsdünker J; Ottmüller KJ; Neeff HP; Koyama M; Gao Z; Thomas OS; Follo M; Al-Ahmad A; Prinz G; Duquesne S; Dierbach H; Kirschnek S; Lämmermann T; Blaser MJ; Fife BT; Blazar BR; Beilhack A; Hill GR; Häcker G; Zeiser R
Blood; 2018 Apr; 131(16):1858-1869. PubMed ID: 29463561
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect.
Choi J; Cooper ML; Alahmari B; Ritchey J; Collins L; Holt M; DiPersio JF
PLoS One; 2014; 9(10):e109799. PubMed ID: 25289677
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic Inhibition of JAK1/JAK2 Signaling Reduces Experimental Murine Acute GVHD While Preserving GVT Effects.
Carniti C; Gimondi S; Vendramin A; Recordati C; Confalonieri D; Bermema A; Corradini P; Mariotti J
Clin Cancer Res; 2015 Aug; 21(16):3740-9. PubMed ID: 25977345
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.
Schwab L; Goroncy L; Palaniyandi S; Gautam S; Triantafyllopoulou A; Mocsai A; Reichardt W; Karlsson FJ; Radhakrishnan SV; Hanke K; Schmitt-Graeff A; Freudenberg M; von Loewenich FD; Wolf P; Leonhardt F; Baxan N; Pfeifer D; Schmah O; Schönle A; Martin SF; Mertelsmann R; Duyster J; Finke J; Prinz M; Henneke P; Häcker H; Hildebrandt GC; Häcker G; Zeiser R
Nat Med; 2014 Jun; 20(6):648-54. PubMed ID: 24836575
[TBL] [Abstract][Full Text] [Related]
5. Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation.
Persaud SP; Ritchey JK; Kim S; Lim S; Ruminski PG; Cooper ML; Rettig MP; Choi J; DiPersio JF
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34730109
[TBL] [Abstract][Full Text] [Related]
6. L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease.
Dutt S; Ermann J; Tseng D; Liu YP; George TI; Fathman CG; Strober S
Blood; 2005 Dec; 106(12):4009-15. PubMed ID: 16105972
[TBL] [Abstract][Full Text] [Related]
7. Immunization against poly-
Hülsdünker J; Thomas OS; Haring E; Unger S; Gonzalo Núñez N; Tugues S; Gao Z; Duquesne S; Cywes-Bentley C; Oyardi O; Kirschnek S; Schmitt-Graeff A; Pabst O; Koenecke C; Duyster J; Apostolova P; Blaser MJ; Becher B; Pier GB; Häcker G; Zeiser R
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20700-20706. PubMed ID: 31527267
[TBL] [Abstract][Full Text] [Related]
8. Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.
Betts BC; Bastian D; Iamsawat S; Nguyen H; Heinrichs JL; Wu Y; Daenthanasanmak A; Veerapathran A; O'Mahony A; Walton K; Reff J; Horna P; Sagatys EM; Lee MC; Singer J; Chang YJ; Liu C; Pidala J; Anasetti C; Yu XZ
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1582-1587. PubMed ID: 29382747
[TBL] [Abstract][Full Text] [Related]
9. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
Zhang Y; Shlomchik WD; Joe G; Louboutin JP; Zhu J; Rivera A; Giannola D; Emerson SG
J Immunol; 2002 Dec; 169(12):7111-8. PubMed ID: 12471148
[TBL] [Abstract][Full Text] [Related]
10. Kinase Inhibition as Treatment for Acute and Chronic Graft-
Braun LM; Zeiser R
Front Immunol; 2021; 12():760199. PubMed ID: 34868001
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia.
Mathew NR; Vinnakota JM; Apostolova P; Erny D; Hamarsheh S; Andrieux G; Kim JS; Hanke K; Goldmann T; Chappell-Maor L; El-Khawanky N; Ihorst G; Schmidt D; Duyster J; Finke J; Blank T; Boerries M; Blazar BR; Jung S; Prinz M; Zeiser R
J Clin Invest; 2020 Mar; 130(3):1315-1329. PubMed ID: 31846439
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity.
Dertschnig S; Evans P; Santos E Sousa P; Manzo T; Ferrer IR; Stauss HJ; Bennett CL; Chakraverty R
J Clin Invest; 2020 Apr; 130(4):1896-1911. PubMed ID: 31917684
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of JAK1/2 inhibition by ruxolitinib in a murine model of chronic graft-versus-host disease.
Ryu DB; Lim JY; Kim TW; Shin S; Lee SE; Park G; Min CK
Exp Hematol; 2021 Jun; 98():36-46.e2. PubMed ID: 33811972
[TBL] [Abstract][Full Text] [Related]
14. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.
Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN
J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786
[TBL] [Abstract][Full Text] [Related]
15. Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse models.
Huarte E; Peel M; Juvekar A; Dubé P; Sarah S; Stephens L; Stewart B; Long B; Czerniak P; Oliver J; Smith P
Immunotherapy; 2021 Aug; 13(12):977-987. PubMed ID: 34184542
[No Abstract] [Full Text] [Related]
16. Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.
Daenthanasanmak A; Iamsawat S; Chakraborty P; Nguyen HD; Bastian D; Liu C; Mehrotra S; Yu XZ
Blood; 2019 Jan; 133(3):266-279. PubMed ID: 30514750
[TBL] [Abstract][Full Text] [Related]
17. Acute graft-vs-host disease: pathobiology and management.
Goker H; Haznedaroglu IC; Chao NJ
Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
[TBL] [Abstract][Full Text] [Related]
18. Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation.
Xing S; Zhang X; Liu JH; Huang X; Zhou P
Clin Exp Immunol; 2019 Jan; 195(1):121-131. PubMed ID: 30317551
[TBL] [Abstract][Full Text] [Related]
19. The lymph node neutrophil.
Hampton HR; Chtanova T
Semin Immunol; 2016 Apr; 28(2):129-36. PubMed ID: 27025975
[TBL] [Abstract][Full Text] [Related]
20. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
